DBV Technologies (DBVT) Exchange Rate Effect (2020 - 2026)
DBV Technologies (DBVT) reported Exchange Rate Effect of -$4.5 million for Q1 2026, down 1000.0% year-over-year from $500000.0 in Q1 2025, and down 488.27% quarter-over-quarter from $1.2 million in Q4 2025.
DBV Technologies (DBVT) Exchange Rate Effect (2020 - 2026) Analysis & Trends
DBV Technologies (DBVT) has 7 years of Exchange Rate Effect data on file, last reported at -$4.5 million in Q1 2026.
- Exchange Rate Effect for Q1 2026 came in at -$4.5 million, down 1000.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.1 million (up 479.78% YoY), and the FY2025 annual result was $8.1 million, up 289.32% from the prior year.
- Exchange Rate Effect declined to -$4.5 million in Q1 2026 per DBVT's latest filing, from $1.2 million in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $20.7 million in Q4 2022 and troughed at -$14.6 million in Q3 2022.
- A 5-year average of -$75411.8 and a median of -$825000.0 in 2025 frame the typical range for Exchange Rate Effect.
- The sharpest annual moves came in 2022 and 2026: Exchange Rate Effect jumped 1132.12% in 2022, then slumped 1000.0% in 2026.
- A 5-year view of Exchange Rate Effect shows it stood at $20.7 million in 2022, then slumped by 69.63% to $6.3 million in 2023, then slumped by 150.89% to -$3.2 million in 2024, then soared by 136.18% to $1.2 million in 2025, then sank by 488.27% to -$4.5 million in 2026.
- Business Quant data shows DBVT's Exchange Rate Effect at -$4.5 million in Q1 2026, $1.2 million in Q4 2025, and -$825000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 8.68 Mn |
| 10 | DBV Technologies | 6.63 Bn | 6.41 Bn | -3.90 Mn | -4.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.50 Mn |
| Mar 31, 2026 | -4.50 Mn |
| Dec 31, 2025 | 1.16 Mn |
| Dec 31, 2025 | 1.16 Mn |
| Sep 30, 2025 | -825,000.00 |
| Sep 30, 2025 | -825,000.00 |
| Jun 30, 2025 | 7.25 Mn |
| Jun 30, 2025 | 7.25 Mn |
| Mar 31, 2025 | 500,000.00 |
| Mar 31, 2025 | 500,000.00 |
| Dec 31, 2024 | -3.20 Mn |
| Dec 31, 2024 | -3.20 Mn |
| Sep 30, 2024 | 2.79 Mn |
| Sep 30, 2024 | 2.79 Mn |
| Jun 30, 2024 | -896,000.00 |
| Jun 30, 2024 | -896,000.00 |
| Mar 31, 2024 | -2.96 Mn |
| Mar 31, 2024 | -2.96 Mn |
| Dec 31, 2023 | 6.29 Mn |
| Dec 31, 2023 | 6.29 Mn |